The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Insulin-like
".
FunFam 1: insulin-like growth factor I isoform X1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 20 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
50 |
A4GUE7 (/ISS)
C5J073 (/ISS)
C5J073 (/ISS)
C5J073 (/ISS)
C5J073 (/ISS)
C5J073 (/ISS)
C5J073 (/ISS)
F1DFL1 (/ISS)
G8HMZ1 (/ISS)
G8HMZ3 (/ISS)
(40 more) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
8 | B0Z6G1 (/IDA) E9M7C7 (/IDA) F1QNT1 (/IDA) M9RX67 (/IDA) P05019 (/IDA) P08025 (/IDA) Q02815 (/IDA) Q90VV9 (/IDA) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
4 | P05017 (/IPI) P05017 (/IPI) P05019 (/IPI) Q90VV9 (/IPI) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
3 | P05017 (/IPI) P05017 (/IPI) P05019 (/IPI) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
2 | P05019 (/IDA) P08025 (/IDA) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Steroid binding GO:0005496
Interacting selectively and non-covalently with a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
|
2 | P16501 (/IDA) P16501 (/IDA) |
Protein serine/threonine kinase activator activity GO:0043539
Binds to and increases the activity of a protein serine/threonine kinase.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
1 | P05019 (/IPI) |
Insulin-like growth factor receptor binding GO:0005159
Interacting selectively and non-covalently with the insulin-like growth factor receptor.
|
1 | P05019 (/IMP) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
1 | P05019 (/IDA) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
1 | P05019 (/TAS) |
Steroid binding GO:0005496
Interacting selectively and non-covalently with a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene.
|
1 | P08025 (/IDA) |
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
|
1 | P08025 (/TAS) |
Protein serine/threonine kinase activator activity GO:0043539
Binds to and increases the activity of a protein serine/threonine kinase.
|
1 | P08025 (/IDA) |
There are 299 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Negative regulation of release of cytochrome c from mitochondria GO:0090201
Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
42 |
P05019 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16501 (/ISS)
P16501 (/ISS)
(32 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
41 |
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16501 (/ISS)
P16501 (/ISS)
P16545 (/ISS)
(31 more) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
32 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
(22 more) |
Positive regulation of glycogen biosynthetic process GO:0045725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
|
32 |
P05017 (/ISS)
P05017 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16545 (/ISS)
(22 more) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
32 |
P05017 (/ISS)
P05017 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16545 (/ISS)
(22 more) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
30 |
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16545 (/ISS)
P16545 (/ISS)
P17647 (/ISS)
(20 more) |
Insulin-like growth factor receptor signaling pathway GO:0048009
The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
|
29 |
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16545 (/ISS)
P16545 (/ISS)
P17647 (/ISS)
P33712 (/ISS)
(19 more) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
25 |
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A091JXD4 (/ISS)
A0A091MYR0 (/ISS)
A0A091N5D6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
(15 more) |
Negative regulation of insulin secretion GO:0046676
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.
|
25 |
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A091JXD4 (/ISS)
A0A091MYR0 (/ISS)
A0A091N5D6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
(15 more) |
Positive regulation of peptide hormone secretion GO:0090277
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
|
25 |
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A091JXD4 (/ISS)
A0A091MYR0 (/ISS)
A0A091N5D6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
(15 more) |
Response to insulin-like growth factor stimulus GO:1990418
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
25 |
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A068F5F7 (/ISS)
A0A091JXD4 (/ISS)
A0A091MYR0 (/ISS)
A0A091N5D6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
A0A093C3P6 (/ISS)
(15 more) |
Response to heat GO:0009408
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
|
21 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
G8HMZ1 (/IDA)
G8HMZ3 (/IDA)
G8HMZ4 (/IDA)
(11 more) |
Neuroblast proliferation GO:0007405
The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
|
20 |
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
F1DFL1 (/IMP)
G8HMZ1 (/IMP)
G8HMZ3 (/IMP)
G8HMZ4 (/IMP)
(10 more) |
Gene expression GO:0010467
The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
20 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
G8HMZ1 (/IDA)
G8HMZ3 (/IDA)
G8HMZ4 (/IDA)
(10 more) |
Vestibulocochlear nerve formation GO:0021650
The process that gives rise to the vestibulocochlear nerve. This process pertains to the initial formation of a structure from unspecified parts. This sensory nerve innervates the membranous labyrinth of the inner ear. The vestibular branch innervates the vestibular apparatus that senses head position changes relative to gravity. The auditory branch innervates the cochlear duct, which is connected to the three bony ossicles which transduce sound waves into fluid movement in the cochlea.
|
20 |
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
F1DFL1 (/IMP)
G8HMZ1 (/IMP)
G8HMZ3 (/IMP)
G8HMZ4 (/IMP)
(10 more) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
20 |
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
F1DFL1 (/IMP)
G8HMZ1 (/IMP)
G8HMZ3 (/IMP)
G8HMZ4 (/IMP)
(10 more) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
20 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
G8HMZ1 (/IDA)
G8HMZ3 (/IDA)
G8HMZ4 (/IDA)
(10 more) |
Negative regulation of insulin secretion GO:0046676
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.
|
20 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
G8HMZ1 (/IDA)
G8HMZ3 (/IDA)
G8HMZ4 (/IDA)
(10 more) |
Cranial ganglion formation GO:0061560
The process that gives rise to a cranial ganglion. This process pertains to the initial formation of a structure from unspecified parts.
|
20 |
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
F1DFL1 (/IMP)
G8HMZ1 (/IMP)
G8HMZ3 (/IMP)
G8HMZ4 (/IMP)
(10 more) |
Cochlea morphogenesis GO:0090103
The process in which the cochlea is generated and organized.
|
20 |
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
C5J073 (/IMP)
F1DFL1 (/IMP)
G8HMZ1 (/IMP)
G8HMZ3 (/IMP)
G8HMZ4 (/IMP)
(10 more) |
Positive regulation of peptide hormone secretion GO:0090277
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
|
20 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
G8HMZ1 (/IDA)
G8HMZ3 (/IDA)
G8HMZ4 (/IDA)
(10 more) |
Response to insulin-like growth factor stimulus GO:1990418
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
20 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
G8HMZ1 (/IDA)
G8HMZ3 (/IDA)
G8HMZ4 (/IDA)
(10 more) |
Positive regulation of glycoprotein biosynthetic process GO:0010560
Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
|
15 |
P05019 (/IMP)
Q13429 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
(5 more) |
Proteoglycan biosynthetic process GO:0030166
The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
15 |
P05019 (/IMP)
Q13429 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
(5 more) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
15 |
P05019 (/IMP)
Q13429 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
(5 more) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
15 |
P05019 (/IMP)
Q13429 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
Q5U743 (/IMP)
(5 more) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
14 |
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F1 (/IDA)
F2X2F2 (/IDA)
F2X2F3 (/IDA)
M9RX67 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
(4 more) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Response to food GO:0032094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
|
13 |
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F1 (/IDA)
F2X2F2 (/IDA)
F2X2F3 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
(3 more) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Negative regulation of sodium:potassium-exchanging ATPase activity GO:1903407
Any process that stops, prevents or reduces the frequency, rate or extent of sodium:potassium-exchanging ATPase activity.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Positive regulation of sodium:potassium-exchanging ATPase activity GO:1903408
Any process that activates or increases the frequency, rate or extent of sodium:potassium-exchanging ATPase activity.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
12 |
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F1 (/IDA)
F2X2F2 (/IDA)
F2X2F3 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
(2 more) |
Hyperosmotic salinity response GO:0042538
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
12 |
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F1 (/IMP)
F2X2F2 (/IMP)
F2X2F3 (/IMP)
P07455 (/IMP)
P07455 (/IMP)
P07455 (/IMP)
(2 more) |
Response to electrical stimulus GO:0051602
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
|
12 |
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F1 (/IDA)
F2X2F2 (/IDA)
F2X2F3 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
(2 more) |
Response to magnetism GO:0071000
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus.
|
12 |
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F1 (/IDA)
F2X2F2 (/IDA)
F2X2F3 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
(2 more) |
Negative regulation of sodium:potassium-exchanging ATPase activity GO:1903407
Any process that stops, prevents or reduces the frequency, rate or extent of sodium:potassium-exchanging ATPase activity.
|
12 |
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F1 (/IMP)
F2X2F2 (/IMP)
F2X2F3 (/IMP)
P07455 (/IMP)
P07455 (/IMP)
P07455 (/IMP)
(2 more) |
Positive regulation of sodium:potassium-exchanging ATPase activity GO:1903408
Any process that activates or increases the frequency, rate or extent of sodium:potassium-exchanging ATPase activity.
|
12 |
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F0 (/IMP)
F2X2F1 (/IMP)
F2X2F2 (/IMP)
F2X2F3 (/IMP)
P07455 (/IMP)
P07455 (/IMP)
P07455 (/IMP)
(2 more) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
4 | P05017 (/IDA) P05017 (/IDA) P05019 (/IDA) P08025 (/IDA) |
Oocyte maturation GO:0001556
A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.
|
3 | B0Z6G1 (/IDA) E9M7C7 (/IDA) F1QNT1 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
3 | P05019 (/IDA) P16545 (/IDA) P16545 (/IDA) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P05017 (/IDA) P05017 (/IDA) P05019 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | P05017 (/IDA) P05017 (/IDA) P08025 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
3 | P05017 (/IDA) P05017 (/IDA) P05019 (/IDA) |
Insulin-like growth factor receptor signaling pathway GO:0048009
The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
|
3 | P05017 (/IDA) P05017 (/IDA) P08025 (/IDA) |
Sperm capacitation GO:0048240
A process required for sperm to reach fertilization competence. Sperm undergo an incompletely understood series of morphological and molecular maturational processes, termed capacitation, involving, among other processes, protein tyrosine phosphorylation and increased intracellular calcium.
|
3 | B0Z6G1 (/IMP) E9M7C7 (/IMP) F1QNT1 (/IMP) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
2 | P05017 (/ISO) P05017 (/ISO) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
2 | P05017 (/IEP) P05017 (/IEP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Negative regulation of immune system process GO:0002683
Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Regulation of translation GO:0006417
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Sensory perception of smell GO:0007608
The series of events required for an organism to receive an olfactory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Olfaction involves the detection of chemical composition of an organism's ambient medium by chemoreceptors. This is a neurological process.
|
2 | P05017 (/TAS) P05017 (/TAS) |
Memory GO:0007613
The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).
|
2 | P05017 (/ISO) P05017 (/ISO) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
2 | P05017 (/IEP) P05017 (/IEP) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Response to heat GO:0009408
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Glial cell differentiation GO:0010001
The process in which a relatively unspecialized cell acquires the specialized features of a glial cell.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P05019 (/IMP) Q13429 (/IMP) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of glycoprotein biosynthetic process GO:0010560
Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of cardiac muscle hypertrophy GO:0010613
Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of muscle cell apoptotic process GO:0010656
Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | A4GUE7 (/IDA) Q91476 (/IDA) |
Skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration GO:0014834
Any process by which the number of skeletal muscle satellite cells in a skeletal muscle is maintained during muscle regeneration. There are at least three mechanisms by which this is achieved. Skeletal muscle satellite stem cell asymmetric division ensures satellite stem cell numbers are kept constant. Symmetric division of these cells amplifies the number of skeletal muscle satellite stem cells. Some adult skeletal muscle myoblasts (descendants of activated satellite cells) can develop back into quiescent satellite cells, replenishing the overall pool of satellite cells.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Muscle hypertrophy GO:0014896
The muscle system process that results in enlargement or overgrowth of all or part of a muscle organ due to an increase in the size of its muscle cells. Physiological hypertrophy is a normal process during development (it stops in cardiac muscle after adolescence) and can also be brought on in response to demand. In athletes cardiac and skeletal muscles undergo hypertrophy stimulated by increasing muscle activity on exercise. Smooth muscle cells in the uterus undergo hypertrophy during pregnancy.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Myotube cell development GO:0014904
The process aimed at the progression of a myotube cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of smooth muscle cell migration GO:0014911
Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of cerebellar granule cell precursor proliferation GO:0021940
The process that activates or increases the rate or extent of granule cell precursor proliferation.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Water homeostasis GO:0030104
Any process involved in the maintenance of an internal steady state of water within an organism or cell.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Proteoglycan biosynthetic process GO:0030166
The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
|
2 | P16501 (/IDA) P16501 (/IDA) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Exocrine pancreas development GO:0031017
The process whose specific outcome is the progression of the exocrine pancreas over time, from its formation to the mature structure. The exocrine pancreas produces and store zymogens of digestive enzymes, such as chymotrypsinogen and trypsinogen in the acinar cells.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Positive regulation of myelination GO:0031643
Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | A4GUE7 (/IDA) Q91476 (/IDA) |
Negative regulation of interleukin-1 beta production GO:0032691
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of tumor necrosis factor production GO:0032720
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Regulation of establishment or maintenance of cell polarity GO:0032878
Any process that modulates the frequency, rate or extent of the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Negative regulation of smooth muscle cell apoptotic process GO:0034392
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Multicellular organism growth GO:0035264
The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Bone mineralization involved in bone maturation GO:0035630
The deposition of hydroxyapatite, involved in the progression of the skeleton from its formation to its mature state.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Hyperosmotic salinity response GO:0042538
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
2 | M9RX67 (/IDA) Q02815 (/IDA) |
Hypotonic salinity response GO:0042539
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
2 | A4GUE7 (/IDA) Q91476 (/IDA) |
Response to starvation GO:0042594
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.
|
2 | A4GUE7 (/IDA) Q91476 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568
Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Regulation of nitric oxide biosynthetic process GO:0045428
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Myoblast differentiation GO:0045445
The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Response to ethanol GO:0045471
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of fat cell differentiation GO:0045600
Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
2 | P05019 (/IDA) P08025 (/IDA) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of glycogen biosynthetic process GO:0045725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of glycolytic process GO:0045821
Any process that activates or increases the frequency, rate or extent of glycolysis.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of Ras protein signal transduction GO:0046579
Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Insulin-like growth factor receptor signaling pathway GO:0048009
The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Phosphatidylinositol-mediated signaling GO:0048015
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Cell development GO:0048468
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Chondroitin sulfate proteoglycan biosynthetic process GO:0050650
The chemical reactions and pathways resulting in the formation of chondroitin sulfate proteoglycan, any glycoprotein whose glycosaminoglycan units are chondroitin sulfate. Chondroitin sulfates are a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues; the repeat units consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P05019 (/IDA) P08025 (/IDA) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of peptidyl-tyrosine phosphorylation GO:0050732
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Detection of mechanical stimulus involved in sensory perception GO:0050974
The series of events in which a mechanical stimulus is received and converted into a molecular signal as part of sensory perception.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Regulation of protein metabolic process GO:0051246
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Myoblast proliferation GO:0051450
The multiplication or reproduction of myoblasts, resulting in the expansion of a myoblast cell population. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Regulation of calcium ion transport GO:0051924
Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of glial cell proliferation GO:0060252
Any process that activates or increases the rate or extent of glial cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of oocyte development GO:0060283
Any process that decreases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
|
2 | P05019 (/IMP) Q13429 (/IMP) |
Negative regulation of oocyte development GO:0060283
Any process that decreases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Head morphogenesis GO:0060323
The process in which the anatomical structures of the head are generated and organized. The head is the anterior-most division of the body.
|
2 | P16501 (/IDA) P16501 (/IDA) |
Lung vasculature development GO:0060426
The biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Lung vasculature development GO:0060426
The biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Lung lobe morphogenesis GO:0060463
The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Lung lobe morphogenesis GO:0060463
The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Type I pneumocyte differentiation GO:0060509
The process in which a relatively unspecialized cell acquires specialized features of a type I pneumocyte. A type I pneumocyte is a flattened cell with greatly attenuated cytoplasm and a paucity of organelles.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Type II pneumocyte differentiation GO:0060510
The process in which a relatively unspecialized cell acquires specialized features of a type II pneumocyte. A type II pneumocyte is a surfactant secreting cell that contains abundant cytoplasm containing numerous lipid-rich multilamellar bodies.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis GO:0060527
The branching morphogenesis process in which the prostate epithelial cords branch freely to create the structure of the prostate acini.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Prostate gland growth GO:0060736
The increase in size or mass of the prostate gland where the increase in size or mass has the specific outcome of the progression of the gland, from its formation to its mature state.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Prostate gland growth GO:0060736
The increase in size or mass of the prostate gland where the increase in size or mass has the specific outcome of the progression of the gland, from its formation to its mature state.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Prostate gland epithelium morphogenesis GO:0060740
The process in which the anatomical structures of epithelia of the prostate gland are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Prostate gland stromal morphogenesis GO:0060741
The process in which the prostate gland stroma is generated and organized. The prostate gland stroma is made up of the mesenchymal or fibroblast cells of the prostate gland.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Negative regulation of androgen receptor signaling pathway GO:0060766
Any process that decreases the rate, frequency, or extent of the androgen receptor signaling pathway.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Positive regulation of cartilage development GO:0061036
Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | M9RX67 (/IDA) Q02815 (/IDA) |
Positive regulation of cell growth involved in cardiac muscle cell development GO:0061051
Any process that increases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
2 | P05017 (/ISO) P05017 (/ISO) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of ERK1 and ERK2 cascade GO:0070373
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P05017 (/IGI) P05017 (/IGI) |
Positive regulation of calcineurin-NFAT signaling cascade GO:0070886
Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Cellular response to glucose stimulus GO:0071333
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Positive regulation of protein serine/threonine kinase activity GO:0071902
Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of steroid hormone biosynthetic process GO:0090031
Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones,compounds with a 1, 2, cyclopentanoperhydrophenanthrene nucleus that act as hormones.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of release of cytochrome c from mitochondria GO:0090201
Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Extrinsic apoptotic signaling pathway in absence of ligand GO:0097192
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Negative regulation of neuroinflammatory response GO:0150079
Any process that stops, prevents or reduces the frequency, rate or extent of neuroinflammatory response.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of oligodendrocyte apoptotic process GO:1900142
Any process that stops, prevents or reduces the frequency, rate or extent of oligodendrocyte apoptotic process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of amyloid-beta formation GO:1902430
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid-beta formation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of trophectodermal cell proliferation GO:1904075
Any process that activates or increases the frequency, rate or extent of trophectodermal cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of cholangiocyte apoptotic process GO:1904193
Any process that stops, prevents or reduces the frequency, rate or extent of cholangiocyte apoptotic process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of vascular associated smooth muscle cell apoptotic process GO:1905460
Any process that stops, prevents or reduces the frequency, rate or extent of vascular associated smooth muscle cell apoptotic process.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Positive regulation of vascular endothelial cell proliferation GO:1905564
Any process that activates or increases the frequency, rate or extent of vascular endothelial cell proliferation.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Cellular response to insulin-like growth factor stimulus GO:1990314
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Positive regulation of myoblast proliferation GO:2000288
Any process that activates or increases the frequency, rate or extent of myoblast proliferation.
|
2 | P05017 (/IMP) P05017 (/IMP) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | P05019 (/IDA) P08025 (/IDA) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
1 | P05019 (/IMP) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
1 | P05019 (/TAS) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P08025 (/IEP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
1 | P05019 (/IDA) |
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
|
1 | P05019 (/TAS) |
Negative regulation of immune system process GO:0002683
Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process.
|
1 | P08025 (/IMP) |
Cardiac atrium development GO:0003230
The process whose specific outcome is the progression of a cardiac atrium over time, from its formation to the mature structure. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle.
|
1 | P08025 (/IEP) |
Regulation of translation GO:0006417
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
|
1 | P08025 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | P05019 (/TAS) |
Ras protein signal transduction GO:0007265
A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
|
1 | P05019 (/TAS) |
Muscle organ development GO:0007517
The process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work.
|
1 | P05019 (/TAS) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
1 | P08025 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | P08025 (/IEP) |
Response to nutrient GO:0007584
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
|
1 | P08025 (/IEP) |
Memory GO:0007613
The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).
|
1 | P08025 (/IMP) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
1 | P05019 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
1 | P05019 (/IMP) |
Glycolate metabolic process GO:0009441
The chemical reactions and pathways involving glycolate, the anion of hydroxyethanoic acid (glycolic acid).
|
1 | P05019 (/TAS) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P08025 (/IEP) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
1 | Q90VV9 (/IMP) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
1 | P08025 (/IEP) |
Positive regulation of cardiac muscle hypertrophy GO:0010613
Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
1 | P05019 (/IDA) |
Positive regulation of cardiac muscle hypertrophy GO:0010613
Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
1 | P05019 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P05019 (/IGI) |
Negative regulation of muscle cell apoptotic process GO:0010656
Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
|
1 | P08025 (/IMP) |
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
|
1 | P05019 (/IMP) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | P08025 (/IEP) |
Response to activity GO:0014823
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
|
1 | P08025 (/IEP) |
Skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration GO:0014834
Any process by which the number of skeletal muscle satellite cells in a skeletal muscle is maintained during muscle regeneration. There are at least three mechanisms by which this is achieved. Skeletal muscle satellite stem cell asymmetric division ensures satellite stem cell numbers are kept constant. Symmetric division of these cells amplifies the number of skeletal muscle satellite stem cells. Some adult skeletal muscle myoblasts (descendants of activated satellite cells) can develop back into quiescent satellite cells, replenishing the overall pool of satellite cells.
|
1 | P05019 (/IDA) |
Muscle hypertrophy GO:0014896
The muscle system process that results in enlargement or overgrowth of all or part of a muscle organ due to an increase in the size of its muscle cells. Physiological hypertrophy is a normal process during development (it stops in cardiac muscle after adolescence) and can also be brought on in response to demand. In athletes cardiac and skeletal muscles undergo hypertrophy stimulated by increasing muscle activity on exercise. Smooth muscle cells in the uterus undergo hypertrophy during pregnancy.
|
1 | P05019 (/IMP) |
Myotube cell development GO:0014904
The process aimed at the progression of a myotube cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
|
1 | P05019 (/IDA) |
Positive regulation of smooth muscle cell migration GO:0014911
Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
|
1 | P05019 (/IDA) |
Proteoglycan biosynthetic process GO:0030166
The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
1 | P05019 (/IDA) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P08025 (/IDA) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P08025 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | P05019 (/IMP) |
Response to caffeine GO:0031000
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them.
|
1 | P08025 (/IEP) |
Response to nutrient levels GO:0031667
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
|
1 | P08025 (/IEP) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
1 | P05019 (/IMP) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | P08025 (/IEP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P08025 (/IEP) |
Negative regulation of interleukin-1 beta production GO:0032691
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.
|
1 | P05019 (/IGI) |
Negative regulation of tumor necrosis factor production GO:0032720
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
1 | P05019 (/IGI) |
Cellular response to insulin stimulus GO:0032869
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
1 | P08025 (/IEP) |
Negative regulation of smooth muscle cell apoptotic process GO:0034392
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.
|
1 | P05019 (/IDA) |
Response to nicotine GO:0035094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
1 | P08025 (/IEP) |
Bone mineralization involved in bone maturation GO:0035630
The deposition of hydroxyapatite, involved in the progression of the skeleton from its formation to its mature state.
|
1 | P05019 (/IDA) |
Regulation of multicellular organism growth GO:0040014
Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
|
1 | P05019 (/IEP) |
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
|
1 | P05019 (/IDA) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | P08025 (/IDA) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
1 | P05019 (/IDA) |
Response to starvation GO:0042594
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.
|
1 | P08025 (/IEP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | P05019 (/IMP) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
1 | P08025 (/IDA) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
1 | P05019 (/IDA) |
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
|
1 | P05019 (/IDA) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
1 | P05019 (/IMP) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
1 | P08025 (/IGI) |
Positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568
Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
1 | P05019 (/IDA) |
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
|
1 | P05019 (/TAS) |
Myoblast differentiation GO:0045445
The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers.
|
1 | P05019 (/IDA) |
Response to ethanol GO:0045471
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
|
1 | P08025 (/IDA) |
Response to ethanol GO:0045471
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
|
1 | P08025 (/IEP) |
Positive regulation of fat cell differentiation GO:0045600
Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
|
1 | P08025 (/IDA) |
Positive regulation of glycogen biosynthetic process GO:0045725
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
|
1 | P05019 (/IDA) |
Positive regulation of glycolytic process GO:0045821
Any process that activates or increases the frequency, rate or extent of glycolysis.
|
1 | P05019 (/IDA) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
1 | P05019 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P05019 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P05019 (/IMP) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
1 | P05019 (/IDA) |
Positive regulation of Ras protein signal transduction GO:0046579
Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction.
|
1 | P05019 (/IDA) |
Insulin-like growth factor receptor signaling pathway GO:0048009
The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
|
1 | P05019 (/IMP) |
Phosphatidylinositol-mediated signaling GO:0048015
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
|
1 | P05019 (/IDA) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
1 | P05019 (/IDA) |
Response to steroid hormone GO:0048545
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
|
1 | P08025 (/IEP) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
1 | P05019 (/IDA) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
1 | P05019 (/IDA) |
Detection of mechanical stimulus involved in sensory perception GO:0050974
The series of events in which a mechanical stimulus is received and converted into a molecular signal as part of sensory perception.
|
1 | P08025 (/IMP) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
1 | P08025 (/IEP) |
Myoblast proliferation GO:0051450
The multiplication or reproduction of myoblasts, resulting in the expansion of a myoblast cell population. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
1 | P05019 (/IDA) |
Regulation of calcium ion transport GO:0051924
Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
1 | P08025 (/IDA) |
Positive regulation of glial cell proliferation GO:0060252
Any process that activates or increases the rate or extent of glial cell proliferation.
|
1 | P08025 (/IDA) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
1 | P08025 (/IEP) |
Cranial suture morphogenesis GO:0060363
The process in which any suture between cranial bones is generated and organized.
|
1 | P08025 (/IEP) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
1 | P08025 (/IEP) |
Positive regulation of cell growth involved in cardiac muscle cell development GO:0061051
Any process that increases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
1 | P05019 (/IDA) |
Positive regulation of cell growth involved in cardiac muscle cell development GO:0061051
Any process that increases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
1 | P05019 (/IGI) |
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade may involve 4 different kinases, as it can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
1 | P05019 (/IMP) |
Response to epidermal growth factor GO:0070849
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
|
1 | P08025 (/IEP) |
Positive regulation of calcineurin-NFAT signaling cascade GO:0070886
Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade.
|
1 | P05019 (/IDA) |
Cellular response to electrical stimulus GO:0071257
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
|
1 | P08025 (/IEP) |
Cellular response to nicotine GO:0071316
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
1 | P08025 (/IEP) |
Cellular response to estradiol stimulus GO:0071392
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | P08025 (/IEP) |
Cellular response to progesterone stimulus GO:0071393
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
1 | P08025 (/IEP) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
1 | P08025 (/IEP) |
Positive regulation of protein serine/threonine kinase activity GO:0071902
Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.
|
1 | P08025 (/IDA) |
Positive regulation of steroid hormone biosynthetic process GO:0090031
Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones,compounds with a 1, 2, cyclopentanoperhydrophenanthrene nucleus that act as hormones.
|
1 | P08025 (/IDA) |
Response to thyroid hormone GO:0097066
A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
|
1 | P08025 (/IEP) |
Negative regulation of neuroinflammatory response GO:0150079
Any process that stops, prevents or reduces the frequency, rate or extent of neuroinflammatory response.
|
1 | P05019 (/IGI) |
Negative regulation of oligodendrocyte apoptotic process GO:1900142
Any process that stops, prevents or reduces the frequency, rate or extent of oligodendrocyte apoptotic process.
|
1 | P08025 (/IDA) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
1 | P08025 (/IDA) |
Negative regulation of amyloid-beta formation GO:1902430
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid-beta formation.
|
1 | P05019 (/IGI) |
Response to L-arginine GO:1903576
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-arginine stimulus.
|
1 | Q6V293 (/IDA) |
Cellular response to Thyroglobulin triiodothyronine GO:1904017
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a Thyroglobulin triiodothyronine stimulus.
|
1 | P08025 (/IEP) |
Positive regulation of trophectodermal cell proliferation GO:1904075
Any process that activates or increases the frequency, rate or extent of trophectodermal cell proliferation.
|
1 | P05019 (/IMP) |
Negative regulation of cholangiocyte apoptotic process GO:1904193
Any process that stops, prevents or reduces the frequency, rate or extent of cholangiocyte apoptotic process.
|
1 | P08025 (/IMP) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
1 | P05019 (/IGI) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
1 | P05019 (/IMP) |
Negative regulation of vascular associated smooth muscle cell apoptotic process GO:1905460
Any process that stops, prevents or reduces the frequency, rate or extent of vascular associated smooth muscle cell apoptotic process.
|
1 | P05019 (/IMP) |
Positive regulation of vascular endothelial cell proliferation GO:1905564
Any process that activates or increases the frequency, rate or extent of vascular endothelial cell proliferation.
|
1 | P08025 (/IGI) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
1 | P05019 (/IDA) |
There are 31 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
41 |
A4GUE7 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F1DFL1 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
(31 more) |
Alphav-beta3 integrin-IGF-1-IGF1R complex GO:0035867
A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits.
|
32 |
P05017 (/ISS)
P05017 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16545 (/ISS)
(22 more) |
Exocytic vesicle GO:0070382
A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis.
|
31 |
P05019 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P07455 (/ISS)
P08025 (/ISS)
P10763 (/ISS)
P10763 (/ISS)
P16545 (/ISS)
P16545 (/ISS)
(21 more) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
30 |
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
C5J073 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
(20 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
13 |
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
A0A023ZTJ1 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
D2IJT0 (/ISS)
G8Z0F4 (/ISS)
G8Z0F4 (/ISS)
(3 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
12 |
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F0 (/IDA)
F2X2F1 (/IDA)
F2X2F2 (/IDA)
F2X2F3 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
P07455 (/IDA)
(2 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
6 | P08025 (/IDA) P16545 (/IDA) P16545 (/IDA) Q0PPT3 (/IDA) Q45QB4 (/IDA) Q45QB4 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
4 | P05019 (/NAS) P16501 (/NAS) P16501 (/NAS) Q90VV9 (/NAS) |
Interstitial matrix GO:0005614
A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P05017 (/HDA) P05017 (/HDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Platelet alpha granule GO:0031091
A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
|
2 | P05017 (/ISO) P05017 (/ISO) |
Alphav-beta3 integrin-IGF-1-IGF1R complex GO:0035867
A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
2 | P05017 (/ISS) P05017 (/ISS) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
2 | P05017 (/TAS) P05017 (/TAS) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
2 | P05017 (/ISO) P05017 (/ISO) |
Exocytic vesicle GO:0070382
A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis.
|
2 | P05017 (/IDA) P05017 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | P05019 (/TAS) |
Interstitial matrix GO:0005614
A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens.
|
1 | P08025 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | P08025 (/IDA) |
Insulin-like growth factor binding protein complex GO:0016942
A complex of proteins which includes the insulin-like growth factor (IGF) and a number of IGF-binding proteins. The complex plays a role in growth and development.
|
1 | P05019 (/IC) |
Platelet alpha granule GO:0031091
A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
|
1 | P08025 (/IDA) |
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
|
1 | P05019 (/TAS) |
Alphav-beta3 integrin-IGF-1-IGF1R complex GO:0035867
A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits.
|
1 | P05019 (/IDA) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
1 | P05019 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
1 | P08025 (/IDA) |